logo

Enanta Pharmaceuticals Inc. (ENTA)



Trade ENTA now with
  Date
  Headline
1/26/2021 7:13:45 AM Enanta Appoints Brendan Luu As SVP, Business Development
1/8/2021 7:10:46 AM Enanta Pharma Says Looks Forward To Continuing Progress Throughout 2021 With Multiple Milestones
1/5/2021 7:04:13 AM Enanta Pharmaceuticals Appoints John DeVincenzo As VP Of Translational Virology
12/8/2020 7:11:26 AM Enanta Pharma Appoints Tara Kieffer As SVP, New Product Strategy And Development
11/23/2020 4:14:34 PM Enanta Pharmaceuticals Q4 Loss/share $1.46 Vs. Profit $0.44 Year Ago
9/14/2020 7:05:55 AM Enanta Doses First Subjects In Its Phase 1 Clinical Trial Of EDP-297
7/9/2020 7:03:14 AM Enanta Announces Advancements In Hepatitis B Virus Program On EDP-514 Across Different Patient Populations
6/29/2020 7:07:08 AM Enanta Pharma Names Mark Foletta To Board
3/13/2020 7:08:28 AM Enanta Pharma Initiates Program To Discover Treatment For Novel Coronavirus Disease COVID-19
3/6/2020 7:07:40 AM Enanta's HCV Collaboration Partner AbbVie Gets Marketing Authorization From EUto Shorten MAVIRET Duration
10/3/2019 7:32:43 AM Enanta Pharma Presents New Data From Its Phase 2a Human Challenge Study Of EDP-938
7/8/2019 7:45:21 AM Enanta Begins Part 1 Of A Phase 1a/b Clinical Study Of EDP-514
6/14/2019 6:03:27 AM Enanta Pharma Says Topline Results Of EDP-938 Achieves Primary & Secondary Endpoints In Phase 2a Human Challenge Study
3/18/2019 7:34:22 AM Enanta Pharmaceuticals Completes Enrollment In Two Ongoing Phase 2 Studies
11/26/2018 4:09:47 PM Enanta Pharmaceuticals Q4 EPS $1.30 Vs. $1.86 Year Ago